Public Health Alerts

Annual Assessment of Student Immunization Records 2024

To: Ottawa Physicians and Nurse Practitioners
Date: November 26, 2024
From: Dr. Trevor Arnason, Deputy Medical Officer of Health
Subject: Annual Assessment of Student Immunization Records

Dear Colleagues,

Ottawa Public Health (OPH) is starting the annual process of assessing childhood immunization records for compliance with the Immunization of School Pupils Act (ISPA).

• To attend school in Ontario, students need to be immunized against nine vaccine preventable diseases or have a medical or...

Read more

Important Update: RSV Monoclonal Antibody (mAb) Beyfortus® Supply

To: Ottawa Physicians and Nurse Practitioners
Date: November 20, 2024
From: Dr. Trevor Arnason, Deputy Medical Officer of Health
Subject: Important Update: RSV Monoclonal Antibody (mAb) Beyfortus® Supply

Dear Colleagues, 

This message follows on the communication sent by Ottawa Public Health (OPH) on November 4, 2024, regarding the supply of monoclonal antibody (mAb) Beyfortus® used for Ontario’s Respiratory Syncytial Virus (RSV) prevention program for infants and high-risk children.

OPH has received...

Read more

Mycoplasma pneumoniae update

To: Ottawa Physicians and Nurse Practitioners
Date: November 18, 2024
From: Dr. Laura Bourns, Associate Medical Officer of Health

Dear Colleagues,

Ottawa Public Health (OPH) would like to share information, provided by Public Health Ontario (PHO) to public health units, regarding Mycoplasma pneumoniae and an increase in M. pneumoniae activity currently being seen in Ontario. 

M. pneumoniae is not a designated Disease of Public Health Significance (‘reportable disease’) and therefore there is no provincial...

Read more

RSV: Monoclonal Antibody (mAb) Beyfortus® Supply and Distribution

To: Ottawa Physicians and Nurse Practitioners
Date: November 4, 2024
From: Dr. Laura Bourns, Associate Medical Officer of Health

Dear Colleagues,

At this time, Ottawa Public Health (OPH) has received a limited supply of monoclonal antibody (mAb) Beyfortus®, the product used for Ontario’s RSV prevention program for infants and high-risk children. OPH is distributing doses to local primary care providers, as per Provincial direction. OPH will continue to provide updates if there are significant changes...

Read more

Ontario Mpox Guidance Updates

To: Ottawa Physicians and Nurse Practitioners
Date: October 16, 2024
From: Dr. Michelle Foote, Associate Medical Officer of Health
Subject: Ontario Mpox Guidance Updates

Dear colleagues,

Ontario has experienced an increase in mpox activity in 2024, and several individuals have tested positive for mpox in Ottawa. Some individuals testing positive in Ottawa have not reported recent travel, providing evidence of local transmission.

The WHO declared a Public Health Emergency of International Concern (PHEIC)...

Read more